"In September, the FDA intends to issue further guidance on the topic of how companies that have already received temporary enforcement discretion could meet FDA requirements to continue to supply infant formula to the U.S. beyond that time. "
If that is subject to regulatory changes, what can they really tell the companies in September?
A2M Price at posting:
$4.90 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)